Back to Journals » Neuropsychiatric Disease and Treatment » Volume 11 » default
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4042)
- Volume 19, 2023 (185)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 11, 2015

Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
Bortolato B, Miskowiak KW, Köhler CA, Vieta E, Carvalho AF
Neuropsychiatric Disease and Treatment 2015, 11:3111-3125
Published Date: 17 December 2015

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex
Mehrabian S, Alexopoulos P, Ortner M, Traykov L, Grimmer T, Kurz A, Förstl H, Bickel H, Diehl-Schmid J
Neuropsychiatric Disease and Treatment 2015, 11:3105-3110
Published Date: 17 December 2015

Lack of tolerable treatment options for patients with schizophrenia
Citrome L, Eramo A, Francois C, Duffy R, Legacy SN, Offord SJ, Krasa HB, Johnston SS, Guiraud-Diawara A, Kamat SA, Rohman P
Neuropsychiatric Disease and Treatment 2015, 11:3095-3104
Published Date: 16 December 2015

Functional connectivity of paired default mode network subregions in primary insomnia
Nie X, Shao Y, Liu SY, Li HJ, Wan AL, Nie S, Peng DC, Dai XJ
Neuropsychiatric Disease and Treatment 2015, 11:3085-3093
Published Date: 16 December 2015

Disturbed spontaneous brain-activity pattern in patients with optic neuritis using amplitude of low-frequency fluctuation: a functional magnetic resonance imaging study
Huang X, Cai FQ, Hu PH, Zhong YL, Zhang Y, Wei R , Pei CG, Zhou FQ, Shao Y
Neuropsychiatric Disease and Treatment 2015, 11:3075-3083
Published Date: 16 December 2015

Altered intrinsic regional spontaneous brain activity in patients with optic neuritis: a resting-state functional magnetic resonance imaging study
Shao Y, Cai FQ, Zhong YL, Huang X, Zhang Y, Hu PH, Pei CG, Zhou FQ, Zeng XJ
Neuropsychiatric Disease and Treatment 2015, 11:3065-3073
Published Date: 11 December 2015

The effects of motivation feedback in patients with severe mental illness: a cluster randomized controlled trial
Jochems EC, van der Feltz-Cornelis CM, van Dam A, Duivenvoorden HJ, Mulder CL
Neuropsychiatric Disease and Treatment 2015, 11:3049-3064
Published Date: 11 December 2015

Coping strategies and quality of life in schizophrenia: cross-sectional study
Holubova M, Prasko J, Hruby R, Kamaradova D, Ociskova M, Latalova K, Grambal A
Neuropsychiatric Disease and Treatment 2015, 11:3041-3048
Published Date: 10 December 2015

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study
Hashimoto T, Sakurai D, Oda Y, Hasegawa T, Kanahara N, Sasaki T, Komatsu H, Takahashi J, Oiwa T, Sekine Y, Watanabe H, Iyo M
Neuropsychiatric Disease and Treatment 2015, 11:3031-3040
Published Date: 10 December 2015


Stress and its association with working efficiency of junior doctors during three postgraduate residency training programs


Abdulghani HM, Al-harbi MM, Irshad M
Neuropsychiatric Disease and Treatment 2015, 11:3023-3029
Published Date: 10 December 2015

Severe arrhythmia induced by orally disintegrating aripiprazole tablets (Bosiqing®): a case report
Shao Q, Quan W, Jia X, Chen J, Ma S, Zhang X
Neuropsychiatric Disease and Treatment 2015, 11:3019-3021
Published Date: 9 December 2015

Asenapine for bipolar disorder
Scheidemantel T, Korobkova I, Rej S, Sajatovic M
Neuropsychiatric Disease and Treatment 2015, 11:3007-3017
Published Date: 4 December 2015

A review of cognitive conflicts research: a meta-analytic study of prevalence and relation to symptoms
Montesano A, López-González MA, Saúl LA, Feixas G
Neuropsychiatric Disease and Treatment 2015, 11:2997-3006
Published Date: 4 December 2015

Psychological changes in alcohol-dependent patients during a residential rehabilitation program
Giorgi I, Ottonello M, Vittadini G, Bertolotti G,
Neuropsychiatric Disease and Treatment 2015, 11:2989-2996
Published Date: 7 December 2015

Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion
Dobek CE, Blumberger DM, Downar J, Daskalakis ZJ, Vila-Rodriguez F
Neuropsychiatric Disease and Treatment 2015, 11:2975-2987
Published Date: 30 November 2015

Profile of brivaracetam and its potential in the treatment of epilepsy
Ferlazzo E, Russo E, Mumoli L, Sueri C, Gasparini S, Palleria C, Labate A, Gambardella A, De Sarro G, Aguglia U
Neuropsychiatric Disease and Treatment 2015, 11:2967-2973
Published Date: 30 November 2015

Long-term effect of early-life stress from earthquake exposure on working memory in adulthood
Li N, Wang Y, Zhao X, Gao Y, Song M, Yu L, Wang L, Li N, Chen Q, Li Y, Cai J, Wang X
Neuropsychiatric Disease and Treatment 2015, 11:2959-2965
Published Date: 26 November 2015

Japanese version of the Munich Parasomnia Screening: translation and linguistic validation of a screening instrument for parasomnias and nocturnal behaviors
Komada Y, Breugelmans R, Fulda S, Nakano S, Watanabe A, Noda C, Nishida S, Inoue Y
Neuropsychiatric Disease and Treatment 2015, 11:2953-2958
Published Date: 25 November 2015

Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials
Maneeton N, Maneeton B, Woottiluk P, Suttajit S, Likhitsathian S, Charnsil C, Srisurapanont M
Neuropsychiatric Disease and Treatment 2015, 11:2943-2952
Published Date: 25 November 2015

The association between the subjective memory complaints scale and depressive state and cognitive impairment: a factor analysis
Tomita T, Yasui-Furukori N, Sugawara N, Takahashi I, Sawada K, Nakamura K
Neuropsychiatric Disease and Treatment 2015, 11:2935-2941
Published Date: 23 November 2015

Relationship between remnant hippocampus and amygdala and memory outcomes after stereotactic surgery for mesial temporal lobe epilepsy
Malikova H, Kramska L, Vojtech Z, Sroubek J, Lukavsky J, Liscak R
Neuropsychiatric Disease and Treatment 2015, 11:2927-2933
Published Date: 19 November 2015

Serum endocan levels in women with restless legs syndrome
Celik K, Cikrikcioglu MA, Halac G, Kilic E, Ayhan S, Ozaras N, Yildiz K, Yildiz RS, Zorlu M, Karatoprak C, Cakirca M, Kiskac M
Neuropsychiatric Disease and Treatment 2015, 11:2919-2925
Published Date: 19 November 2015

Prefrontocerebellar transcranial direct current stimulation increases amplitude and decreases latency of P3b component in patients with euthymic bipolar disorder
Bersani FS, Minichino A, Fattapposta F, Bernabei L, Spagnoli F, Mannarelli D, Francesconi M, Pauletti C, Corrado A, Vergnani L, Taddei I, Biondi M, Delle Chiaie R
Neuropsychiatric Disease and Treatment 2015, 11:2913-2917
Published Date: 19 November 2015

Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases
Akay AP, Kaya GC, Baykara B, Demir Y, Ozek H, Alsen S, Eren MS, Emiroglu NI, Ertay T, Ozturk Y, Miral S, Durak H, Tufan E
Neuropsychiatric Disease and Treatment 2015, 11:2909-2912
Published Date: 19 November 2015

Association between insulin and executive functioning in alcohol dependence: a pilot study
Han C, Bae H, Won SD, Lim J, Kim DJ
Neuropsychiatric Disease and Treatment 2015, 11:2903-2908
Published Date: 16 November 2015

Paroxetine ameliorates changes in hippocampal energy metabolism in chronic mild stress-exposed rats
Khedr LH, Nassar NN, El-Denshary ES, Abdel-tawab AM
Neuropsychiatric Disease and Treatment 2015, 11:2887-2901
Published Date: 13 November 2015

Memantine for the treatment of frontotemporal dementia: a meta-analysis
Kishi T, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2015, 11:2883-2885
Published Date: 12 November 2015

The ability of early changes in motivation to predict later antidepressant treatment response
Gorwood P, Vaiva G, Corruble E, Llorca PM, Baylé FJ, Courtet P
Neuropsychiatric Disease and Treatment 2015, 11:2875-2882
Published Date: 11 November 2015

The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan
Liu WM, Lin RJ, Yu RL, Tai CH, Lin CH, Wu RM
Neuropsychiatric Disease and Treatment 2015, 11:2865-2873
Published Date: 11 November 2015

Early stages of pediatric bipolar disorder: retrospective analysis of a Czech inpatient sample
Goetz M, Novak T, Vesela M, Hlavka Z, Brunovsky M, Povazan M, Ptacek R, Sebela A
Neuropsychiatric Disease and Treatment 2015, 11:2855-2864
Published Date: 4 November 2015

Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
Cui F, Zhu WJ, Zhou ZB, Ren Y, Li YF, Li M, Huo YY, Huang XS
Neuropsychiatric Disease and Treatment 2015, 11:2847-2854
Published Date: 3 November 2015

In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form
Gorbunov EA, Ertuzun IA, Kachaeva EV, Tarasov SA, Epstein OI
Neuropsychiatric Disease and Treatment 2015, 11:2837-2846
Published Date: 3 November 2015

Double encephalitis with herpes simplex virus type II and cytomegalovirus in an elder Chinese: a case report
Xue C, Chen S, Lin Q, Zhou H, Huang C, Lin J, Xie W, Chen K, Zhou D, Ma W, Ma F, Xu H
Neuropsychiatric Disease and Treatment 2015, 11:2833-2836
Published Date: 2 November 2015

Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia
Albayarak Y, Akyol ES, Beyazyüz M, Baykal S, Kuloglu M
Neuropsychiatric Disease and Treatment 2015, 11:2825-2831
Published Date: 29 October 2015

Reliability and validity of the Thai self-report version of the Yale–Brown Obsessive–Compulsive Scale-Second Edition
Hiranyatheb T, Saipanish R, Lotrakul M, Prasertchai R, Ketkaew W, Jullagate S, Udomsubpayakul U, Kusalaruk P
Neuropsychiatric Disease and Treatment 2015, 11:2817-2824
Published Date: 28 October 2015

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
Kudo S, Tomita T, Sugawara N, Sato Y, Ishioka M, Tsuruga K, Nakagami T, Nakamura K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2015, 11:2811-2816
Published Date: 28 October 2015

Connectomics in psychiatric research: advances and applications
Cao M, Wang Z, He Y
Neuropsychiatric Disease and Treatment 2015, 11:2801-2810
Published Date: 29 October 2015

Association study of sepiapterin reductase gene promoter polymorphisms with schizophrenia in a Han Chinese population
Fu JW, Ma GD, Mai H, Luo XD, Yin JW, Chen Q, Lin ZX, Tao H, Li Y, Cui LL, Li Z, Lin JD, Zhao B, Li KS
Neuropsychiatric Disease and Treatment 2015, 11:2793-2799
Published Date: 28 October 2015

Association of EEG, MRI, and regional blood flow biomarkers is predictive of prodromal Alzheimer’s disease
Moretti DV
Neuropsychiatric Disease and Treatment 2015, 11:2779-2791
Published Date: 27 October 2015

Efficacy of physical activity counseling plus sleep restriction therapy on the patients with chronic insomnia
Wang J, Yin G, Li G, Liang W, Wei Q
Neuropsychiatric Disease and Treatment 2015, 11:2771-2778
Published Date: 23 October 2015

Electroencephalography signatures of attention-deficit/hyperactivity disorder: clinical utility
Alba G, Pereda E, Mañas S, Méndez LD, González A, González JJ
Neuropsychiatric Disease and Treatment 2015, 11:2755-2769
Published Date: 22 October 2015

Epidemiological support for genetic variability at hypothalamic–pituitary–adrenal axis and serotonergic system as risk factors for major depression
Ching-López A, Cervilla J, Rivera M, Molina E, McKenney K, Ruiz-Perez I, Rodríguez-Barranco M, Gutiérrez B
Neuropsychiatric Disease and Treatment 2015, 11:2743-2754
Published Date: 22 October 2015

Frequency of anemia in chronic psychiatry patients
Korkmaz S, Yıldız S, Korucu T, Gundogan B, Sunbul ZE, Korkmaz H, Atmaca M
Neuropsychiatric Disease and Treatment 2015, 11:2737-2741
Published Date: 22 October 2015

Effectiveness of a focused, brief psychoeducation program for parents of ADHD children: improvement of medication adherence and symptoms
Bai GN, Wang YF, Yang L, Niu WY
Neuropsychiatric Disease and Treatment 2015, 11:2721-2735
Published Date: 20 October 2015

Neuropsychological and neuroimaging markers in prediction of cognitive impairment after ischemic stroke: a prospective follow-up study
Mehrabian S, Raycheva M, Petrova N, Janyan A, Petrova M, Traykov L
Neuropsychiatric Disease and Treatment 2015, 11:2711-2719
Published Date: 16 October 2015

Motivation for everyday social participation in cognitively able individuals with autism spectrum disorder
Chen YW, Bundy AC, Cordier R, Chien YL, Einfeld SL
Neuropsychiatric Disease and Treatment 2015, 11:2699-2709
Published Date: 15 October 2015

Obstructive sleep apnea: management considerations in psychiatric patients
Heck T, Zolezzi M
Neuropsychiatric Disease and Treatment 2015, 11:2691-2698
Published Date: 15 October 2015

Neurobehavioral burden of multiple sclerosis with nanotheranostics
Sriramoju B, Kanwar RK, Kanwar JR
Neuropsychiatric Disease and Treatment 2015, 11:2675-2689
Published Date: 15 October 2015

Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review
Nguyen L, Marshalek PJ, Weaver CB, Cramer KJ, Pollard SE, Matsumoto RR
Neuropsychiatric Disease and Treatment 2015, 11:2667-2673
Published Date: 14 October 2015

Altered regional homogeneity of spontaneous brain activity in idiopathic trigeminal neuralgia
Wang Y, Zhang X, Guan Q, Wan L, Yi Y, Liu CF
Neuropsychiatric Disease and Treatment 2015, 11:2659-2666
Published Date: 13 October 2015

Ultrastructural mitochondria changes in perihematomal brain and neuroprotective effects of Huperzine A after acute intracerebral hemorrhage
Lu H, Jiang M, Lu L, Zheng G, Dong Q
Neuropsychiatric Disease and Treatment 2015, 11:2649-2657
Published Date: 13 October 2015

Aripiprazole: from pharmacological profile to clinical use
Di Sciascio G, Riva MA
Neuropsychiatric Disease and Treatment 2015, 11:2635-2647
Published Date: 13 October 2015

Increased mean platelet volume in patients with panic disorder
Kokacya MH, Copoglu US, Kivrak Y, Ari M, Sahpolat M, Ulutas KT
Neuropsychiatric Disease and Treatment 2015, 11:2629-2633
Published Date: 13 October 2015

Heart rate variability biofeedback in patients with alcohol dependence: a randomized controlled study
Penzlin AI, Siepmann T, Illigens BMW, Weidner K, Siepmann M
Neuropsychiatric Disease and Treatment 2015, 11:2619-2627
Published Date: 9 October 2015

A case of hypertrophic olivary degeneration after resection of cavernomas of the brain stem and review of the literature
Zhang M, Ye G, Deng L, Xu S, Wang Y
Neuropsychiatric Disease and Treatment 2015, 11:2613-2618
Published Date: 8 October 2015

Predictors of trauma in bank employee robbery victims
Mucci N, Giorgi G, Fiz Perez J, Iavicoli I, Arcangeli G
Neuropsychiatric Disease and Treatment 2015, 11:2605-2612
Published Date: 7 October 2015

Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer’s Disease Neuroimaging Initiative)
Harris P, Fernandez Suarez M, Surace EI, Chrem Méndez P, Martín ME, Clarens MF, Tapajóz F, Russo MJ, Campos J, Guinjoan SM, Sevlever G, Allegri RF
Neuropsychiatric Disease and Treatment 2015, 11:2599-2604
Published Date: 7 October 2015

Effectiveness of cognitive behavioral therapy integrated with systematic desensitization, cognitive behavioral therapy combined with eye movement desensitization and reprocessing therapy, and cognitive behavioral therapy combined with virtual reality exposure therapy methods in the treatment of flight anxiety: a randomized trial
Triscari MT, Faraci P, Catalisano D, D’Angelo V, Urso V
Neuropsychiatric Disease and Treatment 2015, 11:2591-2598
Published Date: 7 October 2015

Clinical correlates of complicated grief among individuals with acute coronary syndromes
Pini S, Gesi C, Abelli M, Cardini A, Lari L, Felice F, Di Stefano R, Mazzotta G, Bovenzi F, Bertoli D, Borelli L, Michi P, Oligeri C, Balbarini A, Manicavasagar V
Neuropsychiatric Disease and Treatment 2015, 11:2583-2589
Published Date: 7 October 2015

Variation of the default mode network with altered alertness levels induced by propofol
Liu XY, Li HD, Luo F, Zhang L, Han RQ, Wang BG
Neuropsychiatric Disease and Treatment 2015, 11:2573-2581
Published Date: 7 October 2015

Electroconvulsive therapy treatment in patients with somatic symptom and related disorders
Leong KW, Tham JCW, Scamvougeras A, Vila-Rodriguez F
Neuropsychiatric Disease and Treatment 2015, 11:2565-2572
Published Date: 6 October 2015

Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
Jeong JH, Bahk WM, Woo YS, Lee KU, Kim DH, Kim MD, Kim W, Yang JC, Lee KH
Neuropsychiatric Disease and Treatment 2015, 11:2557-2564
Published Date: 7 October 2015

Effect of depressive symptoms on the length of hospital stay among patients hospitalized for acute stroke in Japan
Sugawara N, Metoki N, Hagii J, Saito S, Shiroto H, Tomita T, Yasujima M, Okumura K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2015, 11:2551-2556
Published Date: 5 October 2015

Nomenclature of drug-induced pityriasis rosea-like rashes
Chuh AAT
Neuropsychiatric Disease and Treatment 2015, 11:2547-2549
Published Date: 3 October 2015

Virtual reality exposure-based therapy for the treatment of post-traumatic stress disorder: a review of its efficacy, the adequacy of the treatment protocol, and its acceptability
Botella C, Serrano B, Baños RM, Garcia-Palacios A
Neuropsychiatric Disease and Treatment 2015, 11:2533-2545
Published Date: 3 October 2015

Regulation of proteolytic cleavage of brain-derived neurotrophic factor precursor by antidepressants in human neuroblastoma cells
Lin PY
Neuropsychiatric Disease and Treatment 2015, 11:2529-2532
Published Date: 1 October 2015

Psychogenic non-epileptic seizures: so-called psychiatric comorbidity and underlying defense mechanisms
Beghi M, Beffa Negrini P, Perin C, Peroni F, Magaudda A, Cerri C, Cornaggia CM
Neuropsychiatric Disease and Treatment 2015, 11:2519-2527
Published Date: 30 September 2015

Depressogenic medications and other risk factors for depression among Polish patients with epilepsy
Bosak M, Turaj W, Dudek D, Siwek M, Szczudlik A
Neuropsychiatric Disease and Treatment 2015, 11:2509-2517
Published Date: 30 September 2015

Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report
Sato Y, Nakamura K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2015, 11:2505-2507
Published Date: 30 September 2015

Etiology of cardiovascular disease in patients with schizophrenia: current perspectives
Emul M, Kalelioglu T
Neuropsychiatric Disease and Treatment 2015, 11:2493-2503
Published Date: 1 October 2015

A meta-analysis of lipid peroxidation markers in major depression
Mazereeuw G, Herrmann N, Andreazza AC, Khan MM, Lanctôt KL
Neuropsychiatric Disease and Treatment 2015, 11:2479-2491
Published Date: 29 September 2015

Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?
Suttajit S, Arunpongpaisal S, Srisurapanont M, Thavichachart N, Kongsakon R, Chantakarn S, Chantarasak V, Jariyavilas A, Jaroensook P, Kittiwattanagul K, Nerapusee O
Neuropsychiatric Disease and Treatment 2015, 11:2471-2477
Published Date: 29 September 2015

Primary Whipple disease of the brain: case report with long-term clinical and MRI follow-up
Peregrin J, Malikova H
Neuropsychiatric Disease and Treatment 2015, 11:2461-2469
Published Date: 25 September 2015

Metric qualities of the cognitive behavioral assessment for outcome evaluation to estimate psychological treatment effects
Bertolotti G, Michielin P, Vidotto G, Sanavio E, Bottesi G, Bettinardi O, Zotti AM
Neuropsychiatric Disease and Treatment 2015, 11:2449-2460
Published Date: 24 September 2015

Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects
Toker L, Agam G
Neuropsychiatric Disease and Treatment 2015, 11:2441-2447
Published Date: 24 September 2015


First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment


Flórez G, López-Durán A, Triñanes Y, Osorio J, Fraga J, Fernández JM, Becoña E, Arrojo M
Neuropsychiatric Disease and Treatment 2015, 11:2431-2440
Published Date: 24 September 2015

Linking emotional distress to unhealthy sleep duration: analysis of the 2009 National Health Interview Survey
Seixas AA, Nunes JV, Airhihenbuwa CO, Williams NJ, Pandi-Perumal SR, James CC, Jean-Louis G
Neuropsychiatric Disease and Treatment 2015, 11:2425-2430
Published Date: 25 September 2015

Anatomical and functional brain abnormalities in unmedicated major depressive disorder
Yang X, Ma X, Li M, Liu Y, Zhang J, Huang B, Zhao L, Deng W, Li T, Ma X
Neuropsychiatric Disease and Treatment 2015, 11:2415-2423
Published Date: 18 September 2015

Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab

Dubey D, Cano CA, Stuve O
Neuropsychiatric Disease and Treatment 2015, 11:2405-2414
Published Date: 18 September 2015

An innovative intervention for the treatment of cognitive impairment–Emisymmetric bilateral stimulation improves cognitive functions in Alzheimer’s disease and mild cognitive impairment: an open-label study
Guerriero F, Botarelli E, Mele G, Polo L, Zoncu D, Renati P, Sgarlata C, Rollone M, Ricevuti G, Maurizi N, Francis M, Rondanelli M, Perna S, Guido D, Mannu P
Neuropsychiatric Disease and Treatment 2015, 11:2391-2404
Published Date: 18 September 2015

Preliminary findings on the reliability and validity of the Cantonese Birmingham Cognitive Screen in patients with acute ischemic stroke
Pan X, Chen H, Bickerton WL, Lau JKL, Kong APH, Rotshtein P, Guo A, Hu J, Humphreys GW
Neuropsychiatric Disease and Treatment 2015, 11:2377-2390
Published Date: 16 September 2015

Prediction by data mining, of suicide attempts in Korean adolescents: a national study
Bae SM, Lee SA, Lee SH
Neuropsychiatric Disease and Treatment 2015, 11:2367-2375
Published Date: 16 September 2015

Functional neuroimaging of traumatic brain injury: advances and clinical utility
Irimia A, Van Horn JD
Neuropsychiatric Disease and Treatment 2015, 11:2355-2365
Published Date: 15 September 2015

Alzheimer's disease and its treatment costs: case study in the Czech Republic
Mohelska H, Maresova P, Valis M, Kuca K
Neuropsychiatric Disease and Treatment 2015, 11:2349-2354
Published Date: 11 September 2015

Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome
Valencia M, Fresán A, Barak Y, Juárez F, Escamilla R, Saracco R
Neuropsychiatric Disease and Treatment 2015, 11:2339-2348
Published Date: 10 September 2015

Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients
Camardese G, Leone B, Serrani R, Walstra C, Di Nicola M, Della Marca G, Bria P, Janiri L
Neuropsychiatric Disease and Treatment 2015, 11:2331-2338
Published Date: 9 September 2015

Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity
Veauthier C, Gaede G, Radbruch H, Sieb JP, Wernecke KD, Paul F
Neuropsychiatric Disease and Treatment 2015, 11:2323-2329
Published Date: 9 September 2015

Identification of two novel mutations, PSEN1 E280K and PRNP G127S, in a Malaysian family
Ch’ng GS, An SSA, Bae SO, Bagyinszky E, Kim SY
Neuropsychiatric Disease and Treatment 2015, 11:2315-2322
Published Date: 8 September 2015

Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study
Mazereeuw G, Herrmann N, Xu H, Blanchard AP, Figeys D, Oh PI, Bennett SAL, Lanctôt KL
Neuropsychiatric Disease and Treatment 2015, 11:2309-2314
Published Date: 4 September 2015

Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
Oya K, Kishi T, Iwata N
Neuropsychiatric Disease and Treatment 2015, 11:2299-2307
Published Date: 3 September 2015

The effectiveness of racket-sport intervention on visual perception and executive functions in children with mild intellectual disabilities and borderline intellectual functioning
Chen MD, Tsai HY, Wang CC, Wuang YP
Neuropsychiatric Disease and Treatment 2015, 11:2287-2297
Published Date: 2 September 2015

Value of F-wave studies on the electrodiagnosis of carpal tunnel syndrome
Alemdar M
Neuropsychiatric Disease and Treatment 2015, 11:2279-2286
Published Date: 31 August 2015

A validation of wrist actigraphy against polysomnography in patients with schizophrenia or bipolar disorder
Baandrup L, Jennum PJ
Neuropsychiatric Disease and Treatment 2015, 11:2271-2277
Published Date: 28 August 2015

Prefronto–cerebellar transcranial direct current stimulation improves visuospatial memory, executive functions, and neurological soft signs in patients with euthymic bipolar disorder
Minichino A, Bersani FS, Bernabei L, Spagnoli F, Vergnani L, Corrado A, Taddei I, Biondi M, Delle Chiaie R
Neuropsychiatric Disease and Treatment 2015, 11:2265-2270
Published Date: 28 August 2015

Addiction profile in probation practices in Turkey: 5-year data analysis
Yazici AB, Yazici E, Akkisi Kumsar N, Erol A
Neuropsychiatric Disease and Treatment 2015, 11:2259-2263
Published Date: 27 August 2015

Neutrophil-lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy
Demir S, Atli A, Bulut M, İbiloğlu AO, Güneş M, Kaya MC, Demirpençe Ö, Sır A
Neuropsychiatric Disease and Treatment 2015, 11:2253-2258
Published Date: 27 August 2015

The impact of the duration of an untreated episode on improvement of depression and somatic symptoms
Hung CI, Yu NW, Liu CY, Wu KY, Yang CH
Neuropsychiatric Disease and Treatment 2015, 11:2245-2252
Published Date: 27 August 2015

Comorbidity between obsessive-compulsive disorder and body dysmorphic disorder: prevalence, explanatory theories, and clinical characterization
Frías Á, Palma C, Farriols N, González L
Neuropsychiatric Disease and Treatment 2015, 11:2233-2244
Published Date: 26 August 2015

A cross-sectional study on anxiety and stress in pregnant women with chronic HBV infection in the People’s Republic of China
Zhou F, Li JJ, Lin KK, Ji P, Sun YM
Neuropsychiatric Disease and Treatment 2015, 11:2225-2232
Published Date: 25 August 2015

Serum 25-hydroxyvitamin D predicts cognitive performance in adults
Darwish H, Zeinoun P, Ghusn H, Khoury B, Tamim H, Khoury SJ
Neuropsychiatric Disease and Treatment 2015, 11:2217-2223
Published Date: 25 August 2015

The association between sleep patterns and overweight/obesity in Chinese children: a cross-sectional study
Zhang B, Hao YL, Zhou JY, Jia FJ, Li XL, Tang Y, Zheng HR
Neuropsychiatric Disease and Treatment 2015, 11:2209-2216
Published Date: 24 August 2015


Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain?


Henderson TA, Morries LD
Neuropsychiatric Disease and Treatment 2015, 11:2191-2208
Published Date: 21 August 2015

Palliative whole-brain radiotherapy and health-related quality of life for patients with brain metastasis in cancer
Gao Y, Gao F, Ma JL, Zhao DL
Neuropsychiatric Disease and Treatment 2015, 11:2185-2190
Published Date: 21 August 2015

Epidemiology and clinical presentation of stroke in Upper Egypt (desert area)
El Tallawy HN, Farghaly WM, Badry R, Hamdy NA, Shehata GA, Rageh TA, Metwally NA, Hassan EM, Elsayed SS, Yehia MA, Soliman WT
Neuropsychiatric Disease and Treatment 2015, 11:2177-2183
Published Date: 21 August 2015


Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy


Morries LD, Cassano P, Henderson TA
Neuropsychiatric Disease and Treatment 2015, 11:2159-2175
Published Date: 20 August 2015

Psychiatric symptoms and leptin in obese patients who were bariatric surgery candidates
Changchien TC, Tai CM, Huang CK, Chien CC, Yen YC
Neuropsychiatric Disease and Treatment 2015, 11:2153-2158
Published Date: 19 August 2015

Lurasidone for the treatment of bipolar depression: an evidence-based review
Franklin R, Zorowitz S, Corse AK, Widge AS, Deckersbach T
Neuropsychiatric Disease and Treatment 2015, 11:2143-2152
Published Date: 19 August 2015

Employment and the associated impact on quality of life in people diagnosed with schizophrenia
Bouwmans C, de Sonneville C, Mulder CL, Hakkaart-van Roijen L
Neuropsychiatric Disease and Treatment 2015, 11:2125-2142
Published Date: 18 August 2015

Misophonia: current perspectives
Cavanna AE, Seri S
Neuropsychiatric Disease and Treatment 2015, 11:2117-2123
Published Date: 18 August 2015

Childhood adversities and laboratory pain perception
Pieritz K, Rief W, Euteneuer F
Neuropsychiatric Disease and Treatment 2015, 11:2109-2116
Published Date: 19 August 2015

Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain
Ogawa K, Fujikoshi S, Montgomery W, Alev L
Neuropsychiatric Disease and Treatment 2015, 11:2101-2107
Published Date: 18 August 2015

Autophagy dysfunction upregulates beta-amyloid peptides via enhancing the activity of γ-secretase complex
Cai Z, Zhou Y, Liu Z, Ke Z, Zhao B
Neuropsychiatric Disease and Treatment 2015, 11:2091-2099
Published Date: 17 August 2015

The structural equation analysis of childhood abuse, adult stressful life events, and temperaments in major depressive disorders and their influence on refractoriness
Toda H, Inoue T, Tsunoda T, Nakai Y, Tanichi M, Tanaka T, Hashimoto N, Nakato Y, Nakagawa S, Kitaichi Y, Mitsui N, Boku S, Tanabe H, Nibuya M, Yoshino A, Kusumi I
Neuropsychiatric Disease and Treatment 2015, 11:2079-2090
Published Date: 12 August 2015

Poor mental health status and aggression are associated with poor driving behavior among male traffic offenders
Abdoli N, Farnia V, Delavar A, Esmaeili A, Dortaj F, Farrokhi N, Karami M, Shakeri J, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2015, 11:2071-2078
Published Date: 11 August 2015

Mental health status, aggression, and poor driving distinguish traffic offenders from non-offenders but health status predicts driving behavior in both groups
Abdoli N, Farnia V, Delavar A, Esmaeili A, Dortaj F, Farrokhi N, Karami M, Shakeri J, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2015, 11:2063-2070
Published Date: 10 August 2015

Combined application of eicosapentaenoic acid and docosahexaenoic acid on depression in women: a meta-analysis of double-blind randomized controlled trials
Yang JR, Han D, Qiao ZX, Tian X, Qi D, Qiu XH
Neuropsychiatric Disease and Treatment 2015, 11:2055-2061
Published Date: 10 August 2015

Adult attention-deficit hyperactivity disorder, risky behaviors, and motorcycle injuries: a case-control study
Sadeghi-Bazargani H, Abedi L, Mahini M, Amiri S, Khorasani-Zavareh D
Neuropsychiatric Disease and Treatment 2015, 11:2049-2054
Published Date: 7 August 2015

Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia
Kim JH, Lee S, Han AY, Kim K, Lee J
Neuropsychiatric Disease and Treatment 2015, 11:2041-2048
Published Date: 7 August 2015

Relationship between cobalamin deficiency and delirium in elderly patients undergoing cardiac surgery
Sevuk U, Baysal E, Ay N, Altas Y, Altindag R, Yaylak B, Alp V, Demirtas E
Neuropsychiatric Disease and Treatment 2015, 11:2033-2039
Published Date: 7 August 2015

Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms
Urban-Kowalczyk M, Pigońska J, Śmigielski J
Neuropsychiatric Disease and Treatment 2015, 11:2023-2031
Published Date: 6 August 2015

A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study
Wu R, Zhu D, Xia Y, Wang H, Tao W, Xue W, Xia B, Ren L, Zhou X, Li GC, Chen G
Neuropsychiatric Disease and Treatment 2015, 11:2013-2021
Published Date: 6 August 2015

The impact of nocturnal disturbances on daily quality of life in patients with Parkinson’s disease
Yu RL, Tan CH, Wu RM
Neuropsychiatric Disease and Treatment 2015, 11:2005-2012
Published Date: 6 August 2015

Rare and very rare adverse effects of clozapine
De Fazio P, Gaetano R, Caroleo M, Cerminara G, Maida F, Bruno A, Muscatello MR, Jaén Moreno MJ, Russo E, Segura-García C
Neuropsychiatric Disease and Treatment 2015, 11:1995-2003
Published Date: 6 August 2015

The cost reduction in hospitalization associated with paliperidone palmitate in the People’s Republic of China, Korea, and Malaysia
Chiou CF, Wang BCM, Caldwell R, Furnback W, Lee JS, Kothandaraman N, Lee SK, Wang J, Zhang F
Neuropsychiatric Disease and Treatment 2015, 11:1989-1994
Published Date: 5 August 2015

Emotional face recognition deficit in amnestic patients with mild cognitive impairment: behavioral and electrophysiological evidence
Yang L, Zhao X, Wang L, Yu L, Song M, Wang X
Neuropsychiatric Disease and Treatment 2015, 11:1973-1987
Published Date: 5 August 2015

Case-control association study of ABCB1 gene and major depressive disorder in a local Chinese Han population
Xie WW, Zhang L, Wu RR, Yu Y, Zhao JP, Li LH
Neuropsychiatric Disease and Treatment 2015, 11:1967-1971
Published Date: 4 August 2015

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
Zhang XF, Wu L, Wan DJ, Liu RZ, Dong Z, Chen M, Yu SY
Neuropsychiatric Disease and Treatment 2015, 11:1957-1965
Published Date: 4 August 2015

Animal models of obsessive–compulsive disorder: utility and limitations
Alonso P, López-Solà C, Real E, Segalàs C, Menchón JM
Neuropsychiatric Disease and Treatment 2015, 11:1939-1955
Published Date: 4 August 2015

Piano training in youths with hand motor impairments after damage to the developing brain
Lampe R, Thienel A, Mitternacht J, Blumenstein T, Turova V, Alves-Pinto A
Neuropsychiatric Disease and Treatment 2015, 11:1929-1938
Published Date: 3 August 2015

A family-oriented treatment program for youths with ketamine abuse and their caregivers: a pilot study in Taiwan
Wang LJ, Lu SF, Chou WJ, Chong MY, Wang YH, Hsieh YL, Lee YH, Chen C
Neuropsychiatric Disease and Treatment 2015, 11:1921-1927
Published Date: 31 July 2015

Impact of aerobic exercise on sleep and motor skills in children with autism spectrum disorders – a pilot study
Brand S, Jossen S, Holsboer-Trachsler E, Pühse U, Gerber M
Neuropsychiatric Disease and Treatment 2015, 11:1911-1920
Published Date: 5 August 2015

Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice
Dell’Osso B, Albert U, Atti AR, Carmassi C, Carrà G, Cosci F, Del Vecchio V, Di Nicola M, Ferrari S, Goracci A, Iasevoli F, Luciano M, Martinotti G, Nanni MG, Nivoli A, Pinna F, Poloni N, Pompili M, Sampogna G, Tarricone I, Tosato S, Volpe U, Fiorillo A
Neuropsychiatric Disease and Treatment 2015, 11:1885-1909
Published Date: 30 July 2015

Disturbed spontaneous brain activity pattern in patients with primary angle-closure glaucoma using amplitude of low-frequency fluctuation: a fMRI study
Huang X, Zhong YL, Zeng XJ, Zhou F, Liu XH, Hu PH, Pei CG, Shao Y, Dai XJ
Neuropsychiatric Disease and Treatment 2015, 11:1877-1883
Published Date: 29 July 2015


Differential effects of dopamine-directed treatments on cognition


Ashby FG, Valentin VV, von Meer SS
Neuropsychiatric Disease and Treatment 2015, 11:1859-1875
Published Date: 29 July 2015

Association between toll-like receptor 4 expression and symptoms of major depressive disorder
Wu MK, Huang TL, Huang KW, Huang YL, Hung YY
Neuropsychiatric Disease and Treatment 2015, 11:1853-1857
Published Date: 30 July 2015

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
Oda Y, Kanahara N, Kimura H, Watanabe H, Hashimoto K, Iyo M
Neuropsychiatric Disease and Treatment 2015, 11:1845-1851
Published Date: 29 July 2015

Pituitary dysfunction following traumatic brain injury: clinical perspectives
Tanriverdi F, Kelestimur F
Neuropsychiatric Disease and Treatment 2015, 11:1835-1843
Published Date: 27 July 2015

Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials
Cai SL, Lu HF, Bai ZH, Wu RR, Zhao JP
Neuropsychiatric Disease and Treatment 2015, 11:1817-1834
Published Date: 23 July 2015

Altered blood oxygen level-dependent signal variability in chronic post-traumatic stress disorder during symptom provocation

Ke J, Zhang L, Qi R, Xu Q, Li W, Hou C, Zhong Y, Zhang Z, He Z, Li L, Lu G
Neuropsychiatric Disease and Treatment 2015, 11:1805-1815
Published Date: 23 July 2015

Sudden loss of the deep brain stimulation effect with high impedance without macroscopic fracture: a case report and review of the published literature
Yang HJ, Yun JY, Kim YE, Lim YH, Kim HJ, Paek SH, Jeon BS
Neuropsychiatric Disease and Treatment 2015, 11:1799-1803
Published Date: 21 July 2015

Markers of neurodevelopmental impairments in early-onset psychosis
Petruzzelli MG, Margari L, Craig F, Campa MG, Martinelli D, Pastore A, Simone M, Margari F
Neuropsychiatric Disease and Treatment 2015, 11:1793-1798
Published Date: 20 July 2015

Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study
Albert U, De Cori D, Aguglia A, Barbaro F, Lanfranco F, Bogetto F, Maina G
Neuropsychiatric Disease and Treatment 2015, 11:1785-1791
Published Date: 20 July 2015

Acute multiple focal neuropathies and delayed postanoxic encephalopathy after alcohol intoxication
Wang WC, Yang HC, Chen YJ
Neuropsychiatric Disease and Treatment 2015, 11:1781-1784
Published Date: 17 July 2015

Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities
Ociskova M, Prasko J, Kamaradova D, Grambal A, Sigmundova Z
Neuropsychiatric Disease and Treatment 2015, 11:1767-1779
Published Date: 17 July 2015

Disconnection of the hippocampus and amygdala associated with lesion load in relapsing–remitting multiple sclerosis: a structural and functional connectivity study
Zhou F, Zhuang Y, Wang L, Zhang Y, Wu L, Zeng X, Gong H
Neuropsychiatric Disease and Treatment 2015, 11:1749-1765
Published Date: 17 July 2015

The reliability and validity of a Chinese-version Short Health Anxiety Inventory: an investigation of university students
Zhang Y, Liu R, Li G, Mao S, Yuan Y
Neuropsychiatric Disease and Treatment 2015, 11:1739-1747
Published Date: 16 July 2015

Role of apolipoprotein E in neurodegenerative diseases
Giau VV, Bagyinszky E, An SS, Kim SY
Neuropsychiatric Disease and Treatment 2015, 11:1723-1737
Published Date: 16 July 2015

Stress, anxiety, and depression among medical students in a multiethnic setting
Kulsoom B, Afsar NA
Neuropsychiatric Disease and Treatment 2015, 11:1713-1722
Published Date: 16 July 2015

Attitudes of psychiatrists toward obsessive–compulsive disorder patients
Kusalaruk P, Saipanish R, Hiranyatheb T
Neuropsychiatric Disease and Treatment 2015, 11:1703-1711
Published Date: 15 July 2015

Microribonucleic acid dysregulations in children and adolescents with obsessive–compulsive disorder
Kandemir H, Erdal ME, Selek S, İzci Ay Ö, Karababa İF, Ay ME, Kandemir SB, Yılmaz ŞG, Ekinci S, Taşdelen B, Bayazit H
Neuropsychiatric Disease and Treatment 2015, 11:1695-1701
Published Date: 14 July 2015

Relationship between apathy and tumor location, size, and brain edema in patients with intracranial meningioma
Peng Y, Shao C, Gong Y, Wu X, Tang W, Shi S
Neuropsychiatric Disease and Treatment 2015, 11:1685-1693
Published Date: 13 July 2015

Differences in maladaptive schemas between patients suffering from chronic and acute posttraumatic stress disorder and healthy controls
Ahmadian A, Mirzaee J, Omidbeygi M, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2015, 11:1677-1684
Published Date: 10 July 2015

Testing the psychometric properties of a Chinese version of Dementia Management Strategies Scale
Chien WT
Neuropsychiatric Disease and Treatment 2015, 11:1663-1675
Published Date: 9 July 2015

The influence of atypical antipsychotic drugs on sexual function
Just MJ
Neuropsychiatric Disease and Treatment 2015, 11:1655-1661
Published Date: 8 July 2015

Interaction of social role functioning and coping in people with recent-onset attenuated psychotic symptoms: a case study of three Chinese women at clinical high risk for psychosis
Zhang TH, Li HJ, Woodberry KA, Seidman LJ, Chow A, Xiao ZP, Wang JJ
Neuropsychiatric Disease and Treatment 2015, 11:1647-1654
Published Date: 6 July 2015

Efficacy of atropine combined with paroxetine in vagus nerve excitatory panic disorder
Du N, Sun XL
Neuropsychiatric Disease and Treatment 2015, 11:1645-1646
Published Date: 6 July 2015

Early-onset anorexia nervosa in girls with Asperger syndrome
Dudova I, Kocourkova J, Koutek J
Neuropsychiatric Disease and Treatment 2015, 11:1639-1643
Published Date: 2 July 2015

The reduction of volume and fiber bundle connections in the hippocampus of EGR3 transgenic schizophrenia rats
Ma E, Song T, Zhang H, Lu J, Wang L, Zhao Q, Guo R, Li M, Ma G, Lu G, Li K
Neuropsychiatric Disease and Treatment 2015, 11:1625-1638
Published Date: 1 July 2015

Jumping to conclusions in schizophrenia
Evans SL, Averbeck BB, Furl N
Neuropsychiatric Disease and Treatment 2015, 11:1615-1624
Published Date: 1 July 2015

Epidemiological investigation of 264 sporadic cases of ruptured cerebral aneurysm at a single institution in southwest China
Liu H, Zhang TJ, Jiao S, Li BG, Guan J, Wang YX
Neuropsychiatric Disease and Treatment 2015, 11:1609-1614
Published Date: 1 July 2015

Diagnostic and treatment challenges in traumatic brain injury patients with severe neuropsychiatric symptoms: insights into psychiatric practice
Lauterbach MD, Notarangelo PL, Nichols SJ, Lane KS, Koliatsos VE
Neuropsychiatric Disease and Treatment 2015, 11:1601-1607
Published Date: 1 July 2015

Outcome predictors in autism spectrum disorders preschoolers undergoing treatment as usual: insights from an observational study using artificial neural networks
Narzisi A, Muratori F, Buscema M, Calderoni S, Grossi E
Neuropsychiatric Disease and Treatment 2015, 11:1587-1599
Published Date: 30 June 2015

Clinical utility of brain stimulation modalities following traumatic brain injury: current evidence
Li S, Zaninotto AL, Neville IS, Paiva WS, Nunn D, Fregni F
Neuropsychiatric Disease and Treatment 2015, 11:1573-1586
Published Date: 30 June 2015

Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
Jeong JH, Lee JG, Kim MD, Sohn IK, Shim SH, Wang HR, Woo YS, Jon DI, Seo JS, Shin YC, Min KJ, Yoon BH, Bahk WM
Neuropsychiatric Disease and Treatment 2015, 11:1561-1571
Published Date: 26 June 2015

Transcranial magnetic stimulation for the treatment of major depression
Janicak PG, Dokucu ME
Neuropsychiatric Disease and Treatment 2015, 11:1549-1560
Published Date: 26 June 2015

Change in prevalence status for children with developmental delay in Taiwan: a nationwide population-based retrospective study
Kuo HT, Muo CH, Chang YT, Lin CK
Neuropsychiatric Disease and Treatment 2015, 11:1541-1547
Published Date: 24 June 2015

Shen-Qi-Jie-Yu-Fang has antidepressant effects in a rodent model of postpartum depression by regulating the immune organs and subsets of T lymphocytes
Qu M, Tang Q, Li X, Zhao R, Li J, Xu H, Gao Y, Mao Y
Neuropsychiatric Disease and Treatment 2015, 11:1523-1540
Published Date: 23 June 2015

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
Nakagawa R, Ohnishi T, Kobayashi H, Wakamatsu A, Tanimura A, Morita K, Yamaoka T, Usui H, Ogawa Y, Fujino A, Yoshizawa K
Neuropsychiatric Disease and Treatment 2015, 11:1511-1521
Published Date: 22 June 2015

Validity and reliability of the Turkish version of CRAFFT Substance Abuse Screening Test among adolescents
Kandemir H, Aydemir Ö, Ekinci S, Selek S, Kandemir SB, Bayazit H
Neuropsychiatric Disease and Treatment 2015, 11:1505-1509
Published Date: 22 June 2015

Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia
Pawelczyk T, Szymanska B, Grancow-Grabka M, Kotlicka-Antczak M, Pawelczyk A
Neuropsychiatric Disease and Treatment 2015, 11:1493-1503
Published Date: 22 June 2015

Efficacy and safety of flexibly dosed paliperidone palmitate in Chinese patients with acute schizophrenia: an open-label, single-arm, prospective, interventional study
Si TM, Zhang KR, Tang JS, Fang MS, Li KQ, Zhuo JM, Feng Y
Neuropsychiatric Disease and Treatment 2015, 11:1483-1492
Published Date: 22 June 2015

Quetiapine mitigates the ethanol-induced oxidative stress in brain tissue, but not in the liver, of the rat
Han JH, Tian HZ, Lian YY, Yu Y, Lu CB, Li XM, Zhang RL, Xu H
Neuropsychiatric Disease and Treatment 2015, 11:1473-1482
Published Date: 15 June 2015

Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China
Zou YM, Liu J, Tian ZY, Lu D, Zhou YY
Neuropsychiatric Disease and Treatment 2015, 11:1467-1472
Published Date: 15 June 2015

Focus group reflections on the current and future state of cognitive assessment tools in geriatric health care
Whitehead JC, Gambino SA, Richter JD, Ryan JD
Neuropsychiatric Disease and Treatment 2015, 11:1455-1466
Published Date: 12 June 2015

Effect of music intervention on the cognitive and depression status of senior apartment residents in Taiwan
Tai SY, Wang LC, Yang YH
Neuropsychiatric Disease and Treatment 2015, 11:1449-1454
Published Date: 12 June 2015

An exploratory study of the association between SORL1 polymorphisms and sporadic Alzheimer’s disease in the Han Chinese population
Zhang F, Liu X, Wang B, Cheng Z, Zhao X, Zhu J, Wang D, Wang Y, Dong A, Li P, Jin C
Neuropsychiatric Disease and Treatment 2015, 11:1443-1448
Published Date: 12 June 2015

Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed as schizophrenia: complexities in diagnosis and treatment
Huang C, Kang Y, Zhang B, Li B, Qiu C, Liu S, Ren H, Yang Y, Liu X, Li T, Guo W
Neuropsychiatric Disease and Treatment 2015, 11:1437-1442
Published Date: 11 June 2015

Are there distinct subtypes in Tourette syndrome? Pure-Tourette syndrome versus Tourette syndrome-plus, and simple versus complex tics
Eapen V, Robertson MM
Neuropsychiatric Disease and Treatment 2015, 11:1431-1436
Published Date: 11 June 2015

Creutzfeldt-Jakob disease versus anti-LGI1 limbic encephalitis in a patient with progressive cognitive dysfunction, psychiatric symptoms, involuntary facio-brachio-crural movement, and an abnormal electroencephalogram: a case report
Sun L, Cao J, Liu C, Lv Y
Neuropsychiatric Disease and Treatment 2015, 11:1427-1430
Published Date: 11 June 2015

Undertreatment of human immunodeficiency virus in psychiatric inpatients: a cross-sectional study of seroprevalence and associated factors
Gonzalez-Torres MA, Salazar MA, Imaz M, Inchausti L, Ibañez B, Fernandez-Rivas A, Pastor J, Anguiano B, Muñoz P, Ruiz E, Oraa R, Bustamante S, Alvarez de Eulate S, Cisterna R
Neuropsychiatric Disease and Treatment 2015, 11:1421-1426
Published Date: 11 June 2015

Psychiatric symptoms in glioma patients: from diagnosis to management
Boele FW, Rooney AG, Grant R, Klein M
Neuropsychiatric Disease and Treatment 2015, 11:1413-1420
Published Date: 10 June 2015

Cognitive impairment in generalized anxiety disorder revealed by event-related potential N270
Yang Y, Zhang X, Zhu Y, Dai Y, Liu T, Wang Y
Neuropsychiatric Disease and Treatment 2015, 11:1405-1411
Published Date: 3 June 2015

Triptolide attenuates cerebral ischemia and reperfusion injury in rats through the inhibition the nuclear factor kappa B signaling pathway
Jin XQ, Ye F, Zhang JJ, Zhao Y, Zhou XL
Neuropsychiatric Disease and Treatment 2015, 11:1395-1403
Published Date: 3 June 2015

Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population
Otsuka I, Watanabe Y, Hishimoto A, Boku S, Mouri K, Shiroiwa K, Okazaki S, Nunokawa A, Shirakawa O, Someya T, Sora I
Neuropsychiatric Disease and Treatment 2015, 11:1381-1393
Published Date: 2 June 2015

Predictors of quality of life among individuals with schizophrenia
Suttajit S, Pilakanta S
Neuropsychiatric Disease and Treatment 2015, 11:1371-1379
Published Date: 28 May 2015

Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder
Martinez-Raga J, Knecht C, de Alvaro R
Neuropsychiatric Disease and Treatment 2015, 11:1359-1370
Published Date: 28 May 2015

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation
Anand E, Berggren L, Deix C, Tóth Á, McDonnell DP
Neuropsychiatric Disease and Treatment 2015, 11:1349-1357
Published Date: 27 May 2015

Attitudes and beliefs of patients with chronic depression toward antidepressants and depression
Jacob SA, Ab Rahman AF, Hassali MA
Neuropsychiatric Disease and Treatment 2015, 11:1339-1347
Published Date: 27 May 2015

Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats
Shi H, Yang X, Zhao H, Zhang S, Zu J, Zhang W, Shen X, Cui G, Hua F, Yan C
Neuropsychiatric Disease and Treatment 2015, 11:1331-1337
Published Date: 27 May 2015

Brain in flames – animal models of psychosis: utility and limitations
Mattei D, Schweibold R, Wolf SA
Neuropsychiatric Disease and Treatment 2015, 11:1313-1329
Published Date: 27 May 2015

Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial
Kang RY, He Y, Yan YX, Li ZW, Wu YQ, Guo XJ, Liang ZG, Jiang J
Neuropsychiatric Disease and Treatment 2015, 11:1307-1311
Published Date: 27 May 2015

Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis
De Hert M, Eramo A, Landsberg W, Kostic D, Tsai LF, Baker RA
Neuropsychiatric Disease and Treatment 2015, 11:1299-1306
Published Date: 27 May 2015

Being parents with epilepsy: thoughts on its consequences and difficulties affecting their children
Gauffin H, Flensner G, Landtblom AM
Neuropsychiatric Disease and Treatment 2015, 11:1291-1298
Published Date: 27 May 2015

Connectivity pattern differences bilaterally in the cerebellum posterior lobe in healthy subjects after normal sleep and sleep deprivation: a resting-state functional MRI study
Liu XM, Yan ZH, Wang TY, Yang XK, Feng F, Fan LP, Jiang J
Neuropsychiatric Disease and Treatment 2015, 11:1279-1289
Published Date: 26 May 2015

The interventional effects of loving-kindness meditation on positive emotions and interpersonal interactions
He X, Shi W, Han X, Wang N, Zhang N, Wang X
Neuropsychiatric Disease and Treatment 2015, 11:1273-1277
Published Date: 25 May 2015

Olanzapine–valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group
Xu L, Lu Y, Yang Y, Zheng Y, Chen F, Lin Z
Neuropsychiatric Disease and Treatment 2015, 11:1265-1271
Published Date: 25 May 2015

Effectiveness of high-intensity interval training on the mental and physical health of people with chronic schizophrenia
Wu MH, Lee CP, Hsu SC, Chang CM, Chen CY
Neuropsychiatric Disease and Treatment 2015, 11:1255-1263
Published Date: 25 May 2015

Comprehensive family therapy: an effective approach for cognitive rehabilitation in schizophrenia
Cai J, Zhu Y, Zhang W, Wang Y, Zhang C
Neuropsychiatric Disease and Treatment 2015, 11:1247-1253
Published Date: 21 May 2015

Assessment of knowledge, attitude, and practice related to epilepsy: a community-based study
Teferi J, Shewangizaw Z
Neuropsychiatric Disease and Treatment 2015, 11:1239-1246
Published Date: 21 May 2015

Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage
Li YQ, Fang W, Tao L, Li M, Yang YL, Gao YF, Ge SN, Gao L, Zhang B, Li ZH, Zhou W, Wang BL, Li LH
Neuropsychiatric Disease and Treatment 2015, 11:1231-1238
Published Date: 19 May 2015

Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
Babij R, Perumal JS
Neuropsychiatric Disease and Treatment 2015, 11:1221-1229
Published Date: 18 May 2015

Differences in gray matter volume corresponding to delusion and hallucination in patients with schizophrenia compared with patients who have bipolar disorder
Song J, Han DH, Kim SM, Hong JS, Min KJ, Cheong JH, Kim BN
Neuropsychiatric Disease and Treatment 2015, 11:1211-1219
Published Date: 18 May 2015

The relationship of psychological trauma with trichotillomania and skin picking
Özten E, Hızlı Sayar G, Eryılmaz G, Kağan G, Işık S, Karamustafalıoğlu O
Neuropsychiatric Disease and Treatment 2015, 11:1203-1210
Published Date: 15 May 2015

Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders
Ociskova M, Prasko J, Kamaradova D, Grambal A, Kasalova P, Sigmundova Z, Latalova K, Vrbova K
Neuropsychiatric Disease and Treatment 2015, 11:1191-1201
Published Date: 15 May 2015

The cortisol awakening response and major depression: examining the evidence
Dedovic K, Ngiam J
Neuropsychiatric Disease and Treatment 2015, 11:1181-1189
Published Date: 14 May 2015

Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods
Caillava-Santos F, Margis R, Rieder CR
Neuropsychiatric Disease and Treatment 2015, 11:1175-1180
Published Date: 13 May 2015

Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder
Lamberti M, Italiano D, Guerriero L, D’Amico G, Siracusano R, Ingrassia M, Germanò E, Calabrò MP, Spina E, Gagliano A
Neuropsychiatric Disease and Treatment 2015, 11:1169-1174
Published Date: 8 May 2015

High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People’s Republic of China
Xiao JB, Mi WF, Li LZ, Shi Y, Zhang HY
Neuropsychiatric Disease and Treatment 2015, 11:1161-1167
Published Date: 8 May 2015

Ataxia with Parkinsonism and dystonia after intentional inhalation of liquefied petroleum gas
Godani M, Canavese F, Migliorini S, Del Sette M
Neuropsychiatric Disease and Treatment 2015, 11:1157-1159
Published Date: 6 May 2015

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
Levitan MN, Papelbaum M, Nardi AE
Neuropsychiatric Disease and Treatment 2015, 11:1149-1155
Published Date: 5 May 2015

Depressive disorders co-existing with Addison–Biermer anemia – case report
Just MJ, Kozakiewicz M
Neuropsychiatric Disease and Treatment 2015, 11:1145-1148
Published Date: 30 April 2015

Evaluating depressive symptoms in mania: a naturalistic study of patients with bipolar disorder
Young AH, Eberhard J
Neuropsychiatric Disease and Treatment 2015, 11:1137-1143
Published Date: 29 April 2015

In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy
Bazzazi N, Ahmadpanah M, Akbarzadeh S, Seif Rabiei MA, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2015, 11:1131-1136
Published Date: 28 April 2015

Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies
Pan Y, Cai W, Cheng Q, Dong W, An T, Yan J
Neuropsychiatric Disease and Treatment 2015, 11:1121-1130
Published Date: 22 April 2015

Dietary patterns and schizophrenia: a comparison with healthy controls
Tsuruga K, Sugawara N, Sato Y, Saito M, Furukori H, Nakagami T, Nakamura K, Takahashi I, Nakaji S, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2015, 11:1115-1120
Published Date: 22 April 2015

Posterior reversible encephalopathy syndrome in a woman with focal segmental glomerulosclerosis

Chowdhary M, Kabbani AA, Tobey D, Hope TD
Neuropsychiatric Disease and Treatment 2015, 11:1111-1114
Published Date: 21 April 2015

The clinical utility of lurasidone in schizophrenia: patient considerations
Harvey PD
Neuropsychiatric Disease and Treatment 2015, 11:1103-1109
Published Date: 28 April 2015

Factors associated with poor discharge status in patients with status epilepticus at Khon Kaen hospital
Chiewthanakul P, Noppaklao P, Sawanyawisuth K, Tiamkao S
Neuropsychiatric Disease and Treatment 2015, 11:1097-1101
Published Date: 20 April 2015

Comorbid personality disorders among patients with depression
Wongpakaran N, Wongpakaran T, Boonyanaruthee V, Pinyopornpanish M, Intaprasert S
Neuropsychiatric Disease and Treatment 2015, 11:1091-1096
Published Date: 17 April 2015

Strategies to improve medication adherence in patients with schizophrenia: the role of support services
El-Mallakh P, Findlay J
Neuropsychiatric Disease and Treatment 2015, 11:1077-1090
Published Date: 16 April 2015

Catha edulis chewing effects on treatment of paranoid schizophrenic patients
Kotb El-Sayed MI, Amin HK
Neuropsychiatric Disease and Treatment 2015, 11:1067-1076
Published Date: 15 April 2015

Current perspectives on deep brain stimulation for severe neurological and psychiatric disorders
Kocabicak E, Temel Y, Höllig A, Falkenburger B, Tan SK
Neuropsychiatric Disease and Treatment 2015, 11:1051-1066
Published Date: 9 April 2015

Prevalence of distorted body image in young Koreans and its association with age, sex, body weight status, and disordered eating behaviors
Hong SC, Jung YE, Kim MD, Lee CI, Hyun MY, Bahk WM, Yoon BH, Lee KH
Neuropsychiatric Disease and Treatment 2015, 11:1043-1049
Published Date: 9 April 2015

The severe complication of Stevens–Johnson syndrome induced by long-term clozapine treatment in a male schizophrenia patient: a case report
Wu MK, Chung WL, Wu CK, Tseng PT
Neuropsychiatric Disease and Treatment 2015, 11:1039-1041
Published Date: 9 April 2015

Social cognitive and neurocognitive deficits in inpatients with unilateral thalamic lesions — pilot study
Wilkos E, Brown TJ, Slawinska K, Kucharska KA
Neuropsychiatric Disease and Treatment 2015, 11:1031-1038
Published Date: 10 April 2015

Activation of mTOR: a culprit of Alzheimer’s disease?
Cai Z, Chen G, He W, Xiao M, Yan LJ
Neuropsychiatric Disease and Treatment 2015, 11:1015-1030
Published Date: 9 April 2015

Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy
Tanamachi Y, Saruwatari J, Noai M, Kamihashi R, Soraoka H, Yoshimori Y, Ogusu N, Oniki K, Yasui-Furukori N, Ishitsu T, Nakagawa K
Neuropsychiatric Disease and Treatment 2015, 11:1007-1014
Published Date: 7 April 2015


“Recovery” from the diagnosis of autism – and then?


Barnevik Olsson M, Westerlund J, Lundström S, Giacobini M, Fernell E, Gillberg C
Neuropsychiatric Disease and Treatment 2015, 11:999-1005
Published Date: 7 April 2015

Factors associated with group bullying and psychopathology in elementary school students using child-welfare facilities
Kim JW, Lee K, Lee YS, Han DH, Min KJ, Song SH, Park GN, Lee JY, Kim JO
Neuropsychiatric Disease and Treatment 2015, 11:991-998
Published Date: 7 April 2015

Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China
Wu J, He XN, Liu L, Ye W, Montgomery W, Xue HB, McCombs JS
Neuropsychiatric Disease and Treatment 2015, 11:983-990
Published Date: 7 April 2015

Neuromodulation and antenatal depression: a review
Kim DR, Snell JL, Ewing GC, O’Reardon J
Neuropsychiatric Disease and Treatment 2015, 11:975-982
Published Date: 7 April 2015

Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
Atake K, Yoshimura R, Hori H, Katsuki A, Nakamura J
Neuropsychiatric Disease and Treatment 2015, 11:967-974
Published Date: 3 April 2015

Psychosurgery for stuttering
Durand E, Weil AG, Lévêque M
Neuropsychiatric Disease and Treatment 2015, 11:963-965
Published Date: 2 April 2015

Neuropsychological and neurophysiological insights into hoarding disorder
Grisham JR, Baldwin PA
Neuropsychiatric Disease and Treatment 2015, 11:951-962
Published Date: 2 April 2015

Catatonia in Down syndrome; a treatable cause of regression
Ghaziuddin N, Nassiri A, Miles JH
Neuropsychiatric Disease and Treatment 2015, 11:941-949
Published Date: 2 April 2015

Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data
Kuwabara H, Saito Y, Mahlich J
Neuropsychiatric Disease and Treatment 2015, 11:935-940
Published Date: 1 April 2015

Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review
Chen YW, Lin PY, Tu KY, Cheng YS, Wu CK, Tseng PT
Neuropsychiatric Disease and Treatment 2015, 11:925-933
Published Date: 1 April 2015

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
Alkhadhari S, Al Zain N, Darwish T, Khan S, Okasha T, Ramy H, Tadros TM
Neuropsychiatric Disease and Treatment 2015, 11:915-924
Published Date: 1 April 2015

Atypical antipsychotics in the treatment of early-onset schizophrenia
Hrdlicka M, Dudova I
Neuropsychiatric Disease and Treatment 2015, 11:907-913
Published Date: 1 April 2015

An association study between DLGAP1 rs11081062 and EFNA5 rs26728 polymorphisms with obsessive–compulsive disorder in a Chinese Han population
Li J, Cui J, Wang X, Ma J, Niu H, Ma X, Zhang X, Liu S
Neuropsychiatric Disease and Treatment 2015, 11:897-905
Published Date: 1 April 2015

A cross-sectional study on perception of stigma by Chinese schizophrenia patients [Retraction]
Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY
Neuropsychiatric Disease and Treatment 2015, 11:895-896
Published Date: 1 April 2015

High prevalence of sleep and mood disorders in dry eye patients: survey of 1,000 eye clinic visitors
Ayaki M, Kawashima M, Negishi K, Tsubota K
Neuropsychiatric Disease and Treatment 2015, 11:889-894
Published Date: 31 March 2015

Major depressive disorder: mechanism-based prescribing for personalized medicine
Saltiel PF, Silvershein DI
Neuropsychiatric Disease and Treatment 2015, 11:875-888
Published Date: 31 March 2015

Aripiprazole-associated tic in a schizophrenia patient
Guo X, Lu D, Jiang Y
Neuropsychiatric Disease and Treatment 2015, 11:873-874
Published Date: 30 March 2015

Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
Akyol ES, Albayrak Y, Beyazyüz M, Aksoy N, Kuloglu M, Hashimoto K
Neuropsychiatric Disease and Treatment 2015, 11:865-872
Published Date: 30 March 2015

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
Wani RA, Dar MA, Chandel RK, Rather YH, Haq I, Hussain A, Malla AA
Neuropsychiatric Disease and Treatment 2015, 11:863-864
Published Date: 30 March 2015

Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
Iancu I, Pick N, Seener-Lorsh O, Dannon P
Neuropsychiatric Disease and Treatment 2015, 11:853-862
Published Date: 27 March 2015

Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study
Gutiérrez-Fernández J, Luna del Castillo JD, Mañanes-González S, Carrillo-Ávila JA, Gutiérrez B, Cervilla JA, Sorlózano-Puerto A
Neuropsychiatric Disease and Treatment 2015, 11:843-852
Published Date: 27 March 2015

Effects of prolonged head-down bed rest on working memory
Liu Q, Zhou R, Zhao X, Oei TPS
Neuropsychiatric Disease and Treatment 2015, 11:835-842
Published Date: 26 March 2015

Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis
Yang X, Wang G, Wang Y, Yue X
Neuropsychiatric Disease and Treatment 2015, 11:823-833
Published Date: 25 March 2015

Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review
Miguel CS, Chaim-Avancini TM, Silva MA, Louzã MR
Neuropsychiatric Disease and Treatment 2015, 11:815-821
Published Date: 25 March 2015

Physical activity as a protective factor against depressive symptoms in older Chinese veterans in the community: result from a national cross-sectional study
Du WJ, Tan JP, Yi F, Zou YM, Gao Y, Zhao YM, Wang LN
Neuropsychiatric Disease and Treatment 2015, 11:803-813
Published Date: 23 March 2015

Prevalence and correlates of attention-deficit hyperactivity disorder symptoms in Korean college students
Kwak YS, Jung YE, Kim MD
Neuropsychiatric Disease and Treatment 2015, 11:797-802
Published Date: 23 March 2015

Forehead carbuncle with intractable headache

Chou PY, Chen YC, Huang P
Neuropsychiatric Disease and Treatment 2015, 11:793-795
Published Date: 20 March 2015

Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
Wang HR, Woo YS, Jun TY, Bahk WM
Neuropsychiatric Disease and Treatment 2015, 11:787-792
Published Date: 20 March 2015

Decisional impairments in cocaine addiction, reward bias, and cortical oscillation “unbalance”
Balconi M, Finocchiaro R
Neuropsychiatric Disease and Treatment 2015, 11:777-786
Published Date: 20 March 2015

Neuroinflammatory responses to traumatic brain injury
Paiva WS, Correia AD, Marie SK
Neuropsychiatric Disease and Treatment 2015, 11:773-776
Published Date: 19 March 2015

Long-term total sleep deprivation decreases the default spontaneous activity and connectivity pattern in healthy male subjects: a resting-state fMRI study
Dai XJ, Liu CL, Zhou RL, Gong HH, Wu B, Gao L, Wang YX
Neuropsychiatric Disease and Treatment 2015, 11:761-772
Published Date: 19 March 2015

Optimal management of night eating syndrome: challenges and solutions
Kucukgoncu S, Midura M, Tek C
Neuropsychiatric Disease and Treatment 2015, 11:751-760
Published Date: 19 March 2015

Effects of a selective educational system on fatigue, sleep problems, daytime sleepiness, and depression among senior high school adolescents in Taiwan
Chen TY, Chou YC, Tzeng NS, Chang HA, Kuo SC, Pan PY, Yeh YW, Yeh CB, Mao WC
Neuropsychiatric Disease and Treatment 2015, 11:741-750
Published Date: 19 March 2015

Red cell distribution width and neurological scoring systems in acute stroke patients
Kara H, Degirmenci S, Bayir A, Ak A, Akinci M, Dogru A, Akyurek F, Kayis SA
Neuropsychiatric Disease and Treatment 2015, 11:733-739
Published Date: 18 March 2015

The influence of comorbid personality disorders on recovery from depression
Wongpakaran T, Wongpakaran N, Boonyanaruthee V, Pinyopornpanish M, Intaprasert S
Neuropsychiatric Disease and Treatment 2015, 11:725-732
Published Date: 16 March 2015

Psychobiotics and the gut–brain axis: in the pursuit of happiness
Zhou L, Foster JA
Neuropsychiatric Disease and Treatment 2015, 11:715-723
Published Date: 16 March 2015

Augmentation with antidepressants in schizophrenia treatment: benefit or risk
Mao YM, Zhang MD
Neuropsychiatric Disease and Treatment 2015, 11:701-713
Published Date: 16 March 2015

Do physical exercise and reading reduce the risk of Parkinson’s disease? a cross-sectional study on factors associated with Parkinson’s disease in elderly Chinese veterans
Zou YM, Tan JP, Li N, Yang JS, Yu BC, Yu JM, Zhao YM, Wang LN
Neuropsychiatric Disease and Treatment 2015, 11:695-700
Published Date: 16 March 2015


Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study


Wani RA, Dar MA, Chandel RK, Rather YH, Haq I, Hussain A, Malla AA
Neuropsychiatric Disease and Treatment 2015, 11:685-693
Published Date: 13 March 2015

Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey
Vietri J, Otsubo T, Montgomery W, Tsuji T, Harada E
Neuropsychiatric Disease and Treatment 2015, 11:675-683
Published Date: 13 March 2015

Impact of incarceration in Nazi concentration camps on multimorbidity of former prisoners
Jablonski RK, Leszek J, Rosińczuk J, Uchmanowicz I, Panaszek B
Neuropsychiatric Disease and Treatment 2015, 11:669-674
Published Date: 11 March 2015

Efficacy, safety, and impact on hospitalizations of paliperidone palmitate in recent-onset schizophrenia
Zhang F, Si T, Chiou CF, Harris AWF, Kim CY, Jahagirdar P, Ascher S
Neuropsychiatric Disease and Treatment 2015, 11:657-668
Published Date: 11 March 2015

A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom
Raluy-Callado M, Gabriel S, Dinet J, Wang M, Wasiak R
Neuropsychiatric Disease and Treatment 2015, 11:647-655
Published Date: 9 March 2015

Global and regional brain volumes normalization in weight-recovered adolescents with anorexia nervosa: preliminary findings of a longitudinal voxel-based morphometry study
Bomba M, Riva A, Morzenti S, Grimaldi M, Neri F, Nacinovich R
Neuropsychiatric Disease and Treatment 2015, 11:637-645
Published Date: 9 March 2015

Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial
Farnia V, Shirzadifar M, Shakeri J, Rezaei M, Bajoghli H, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2015, 11:625-635
Published Date: 9 March 2015

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
Masopust J, Andrýs C, Bažant J, Vyšata O, Kuca K, Vališ M
Neuropsychiatric Disease and Treatment 2015, 11:619-623
Published Date: 6 March 2015

Buprenorphine, methadone, and morphine treatment during pregnancy: behavioral effects on the offspring in rats
Chen HH, Chiang YC, Yuan ZF, Kuo CC, Lai MD, Hung TW, Ho IK, Chen ST
Neuropsychiatric Disease and Treatment 2015, 11:609-618
Published Date: 6 March 2015

Changes in proinflammatory cytokines and white matter in chronically stressed rats
Yang P, Gao Z, Zhang H, Fang Z, Wu C, Xu H, Huang QJ
Neuropsychiatric Disease and Treatment 2015, 11:597-607
Published Date: 6 March 2015

Quality of life of patients with schizophrenia treated in foster home care and in outpatient treatment
Mihanović M, Restek-Petrović B, Bogović A, Ivezić E, Bodor D, Požgain I
Neuropsychiatric Disease and Treatment 2015, 11:585-595
Published Date: 5 March 2015

Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia
Frydecka D, Misiak B, Pawlak-Adamska E, Karabon L, Tomkiewicz A, Sedlaczek P, Kiejna A, Beszłej JA
Neuropsychiatric Disease and Treatment 2015, 11:575-584
Published Date: 5 March 2015

Impaired mitochondrial energy metabolism as a novel risk factor for selective onset and progression of dementia in oldest-old subjects
Zhao W, Wang J, Varghese M, Ho L, Mazzola P, Haroutunian V, Katsel PL, Gibson GE, Levine S, Dubner L, Pasinetti GM
Neuropsychiatric Disease and Treatment 2015, 11:565-574
Published Date: 5 March 2015


Is it possible to use highly realistic virtual reality in the elderly? A feasibility study with image-based rendering


Benoit M, Guerchouche R, Petit PD, Chapoulie E, Manera V, Chaurasia G, Drettakis G, Robert P
Neuropsychiatric Disease and Treatment 2015, 11:557-563
Published Date: 3 March 2015

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
Ranjbar F, Sadeghi-Bazargani H, Niari Khams P, Arfaie A, Salari A, Farahbakhsh M
Neuropsychiatric Disease and Treatment 2015, 11:549-555
Published Date: 2 March 2015

Cattle encephalon glycoside and ignotin injection improves cognitive impairment in APPswe/PS1dE9 mice used as multitarget anti-Alzheimer’s drug candidates
Gao Y, Hu YZ, Li RS, Han ZT, Geng Y, Xia Z, Du WJ, Liu LX, Zhang HH, Wang LN
Neuropsychiatric Disease and Treatment 2015, 11:537-548
Published Date: 27 February 2015

Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study
Strzelecki D, Szyburska J, Kotlicka-Antczak M, Kałużyńska O
Neuropsychiatric Disease and Treatment 2015, 11:533-536
Published Date: 27 February 2015

Toward an online cognitive and emotional battery to predict treatment remission in depression
Gordon E, Rush AJ, Palmer DM, Braund TA, Rekshan W
Neuropsychiatric Disease and Treatment 2015, 11:517-531
Published Date: 26 February 2015

Minocycline upregulates cyclic AMP response element binding protein and brain-derived neurotrophic factor in the hippocampus of cerebral ischemia rats and improves behavioral deficits
Zhao Y, Xiao M, He W, Cai Z
Neuropsychiatric Disease and Treatment 2015, 11:507-516
Published Date: 26 February 2015

Korean Medication Algorithm Project for Bipolar Disorder: third revision
Woo YS, Lee JG, Jeong JH, Kim MD, Sohn IK, Shim SH, Jon DI, Seo JS, Shin YC, Min KJ, Yoon BH, Bahk WM
Neuropsychiatric Disease and Treatment 2015, 11:493-506
Published Date: 26 February 2015

A case-control proton magnetic resonance spectroscopy study confirms cerebellar dysfunction in benign adult familial myoclonic epilepsy

Long L, Song Y, Zhang L, Hu C, Gong J, Xu L, Long H, Zhou L, Zhang Y, Zhang Y, Xiao B
Neuropsychiatric Disease and Treatment 2015, 11:485-491
Published Date: 25 February 2015

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
Ishioka M, Yasui-Furukori N, Sugawara N, Furukori H, Kudo S, Nakamura K
Neuropsychiatric Disease and Treatment 2015, 11:477-484
Published Date: 24 February 2015

Effect of stent-assisted angioplasty on cognitive status and serum levels of amyloid beta in patients with intracranial and/or extracranial artery stenosis
Zhao L, Zhao Y, Zhang H
Neuropsychiatric Disease and Treatment 2015, 11:471-475
Published Date: 24 February 2015

Electroencephalography reveals lower regional blood perfusion and atrophy of the temporoparietal network associated with memory deficits and hippocampal volume reduction in mild cognitive impairment due to Alzheimer’s disease

Moretti DV
Neuropsychiatric Disease and Treatment 2015, 11:461-470
Published Date: 23 February 2015

Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia
Terzić T, Kastelic M, Dolžan V, Plesničar BK
Neuropsychiatric Disease and Treatment 2015, 11:453-459
Published Date: 20 February 2015

Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression
Kato M, Kimura T, Kimura T, Hara T
Neuropsychiatric Disease and Treatment 2015, 11:435-452
Published Date: 20 February 2015

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
Kishi T, Matsuda Y, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2015, 11:419-434
Published Date: 20 February 2015

Coexistence of anxiety sensitivity and psychiatric comorbidities in patients with chronic tinnitus
Gül Aİ, Özkırış M, Aydın R, Şimşek G, Saydam L
Neuropsychiatric Disease and Treatment 2015, 11:413-418
Published Date: 19 February 2015

Untreated depression in the first trimester of pregnancy leads to postpartum depression: high rates from a natural follow-up study
Yazici E, Kirkan TS, Aslan PA, Aydin N, Yazici AB
Neuropsychiatric Disease and Treatment 2015, 11:405-411
Published Date: 19 February 2015

The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder
Akbarian F, Bajoghli H, Haghighi M, Kalak N, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2015, 11:395-404
Published Date: 19 February 2015

The clinical basis of orthorexia nervosa: emerging perspectives
Koven NS, Abry AW
Neuropsychiatric Disease and Treatment 2015, 11:385-394
Published Date: 18 February 2015

One-year follow-up in patients with brainstem infarction due to large-artery atherothrombosis

Kolukısa M, Ozdemir Gültekin T, Eryigit Baran G, Aralasmak A, Kocaman G, Gürsoy AE, Asil T
Neuropsychiatric Disease and Treatment 2015, 11:379-384
Published Date: 18 February 2015

Neurosyphilis with psychotic symptoms and Parkinsonism in a young girl
Yin L, Zou S, Huang Y
Neuropsychiatric Disease and Treatment 2015, 11:375-377
Published Date: 16 February 2015

MRI-guided stereotactic amygdalohippocampectomy: a single center experience
Vojtěch Z, Malíková H, Krámská L, Liščák R, Vladyka V
Neuropsychiatric Disease and Treatment 2015, 11:359-374
Published Date: 11 February 2015

The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports
Kurita M, Nishino S, Numata Y, Okubo Y, Sato T
Neuropsychiatric Disease and Treatment 2015, 11:353-358
Published Date: 11 February 2015

Psychopathology, symptoms of attention-deficit/hyperactivity disorder, and risk factors in juvenile offenders
Margari F, Craig F, Margari L, Matera E, Lamanna AL, Lecce PA, La Tegola D, Carabellese F
Neuropsychiatric Disease and Treatment 2015, 11:343-352
Published Date: 10 February 2015

Remission of classic rapid cycling bipolar disorder with levothyroxine augmentation therapy in a male patient having clinical hypothyroidism
Chen PH, Huang YJ
Neuropsychiatric Disease and Treatment 2015, 11:339-342
Published Date: 10 February 2015

Common psychocutaneous disorders in children

Chiriac A, Brzezinski P, Pinteala T, Chiriac AE, Foia L
Neuropsychiatric Disease and Treatment 2015, 11:333-337
Published Date: 9 February 2015

Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study
Fereshtehnejad SM, Shafieesabet M, Rahmani A, Delbari A, Lökk J
Neuropsychiatric Disease and Treatment 2015, 11:321-332
Published Date: 5 February 2015

Diffuse cerebral vasospasm after resection of schwannoma: a case report

Qi J,Zhang LW, Jia W, Zhang JT, Wu Z
Neuropsychiatric Disease and Treatment 2015, 11:317-320
Published Date: 5 February 2015

The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
Tousi B
Neuropsychiatric Disease and Treatment 2015, 11:311-315
Published Date: 5 February 2015

Neuroprotective strategies against calpain-mediated neurodegeneration
Yildiz-Unal A, Korulu S, Karabay A
Neuropsychiatric Disease and Treatment 2015, 11:297-310
Published Date: 5 February 2015

Adjunct effect of music therapy on cognition in Alzheimer’s disease in Taiwan: a pilot study
Li CH, Liu CK, Yang YH, Chou MC, Chen CH, Lai CL
Neuropsychiatric Disease and Treatment 2015, 11:291-296
Published Date: 4 February 2015

Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression
Haybaeck J, Postruznik M, Miller CL, Dulay JR, Llenos IC, Weis S
Neuropsychiatric Disease and Treatment 2015, 11:279-289
Published Date: 4 February 2015

Increased risk of posterior circulation infarcts among ischemic stroke patients with cervical spondylosis
Chen CC, Chung CY, Lee TH, Chang WH, Tang SF, Pei YC
Neuropsychiatric Disease and Treatment 2015, 11:273-278
Published Date: 3 February 2015

Perfectionism related to self-reported insomnia severity, but not when controlled for stress and emotion regulation
Brand S, Kirov R, Kalak N, Gerber M, Pühse U, Lemola S, Correll CU, Cortese S, Meyer T, Holsboer-Trachsler E
Neuropsychiatric Disease and Treatment 2015, 11:263-271
Published Date: 3 February 2015

Neural correlates of delusional infestation responding to aripiprazole monotherapy: a case report
Ponson L, Andersson F, El-Hage W
Neuropsychiatric Disease and Treatment 2015, 11:257-261
Published Date: 2 February 2015

Neuroinflammation in Alzheimer’s disease
Zhang FJ, Jiang LL
Neuropsychiatric Disease and Treatment 2015, 11:243-256
Published Date: 30 January 2015

The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region
Terroni L, Amaro Jr E, Iosifescu DV, Mattos P, Yamamoto FI, Tinone G, Conforto AB, Sobreiro MFM, Guajardo VD, De Lucia MC, Moreira AC, Scaff M, Leite CC, Fraguas R
Neuropsychiatric Disease and Treatment 2015, 11:233-242
Published Date: 3 February 2015

Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study
Hsu YC, Chou YC, Chang HA, Kao YC, Huang SY, Tzeng NS
Neuropsychiatric Disease and Treatment 2015, 11:225-232
Published Date: 27 January 2015

Changes in background electroencephalography and regional cerebral glucose metabolism in focal epilepsy patients after 1-month administration of levetiracetam

Kim SH, Lim SC, Kim W, Kwon OH, Kim CM, Lee JM, Shon YM
Neuropsychiatric Disease and Treatment 2015, 11:215-223
Published Date: 27 January 2015

Aberrant spontaneous low-frequency brain activity in male patients with severe obstructive sleep apnea revealed by resting-state functional MRI
Li HJ, Dai XJ, Gong HH, Nie X, Zhang W, Peng DC
Neuropsychiatric Disease and Treatment 2015, 11:207-214
Published Date: 23 January 2015

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study
Novick D, Hong J, Montgomery W, Dueñas H, Gado M, Haro JM
Neuropsychiatric Disease and Treatment 2015, 11:197-205
Published Date: 22 January 2015

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
Hongkaew Y, Ngamsamut N, Puangpetch A, Vanwong N, Srisawasdi P, Chamnanphon M, Chamkrachchangpada B, Tan-kam T, Limsila P, Sukasem C
Neuropsychiatric Disease and Treatment 2015, 11:191-196
Published Date: 22 January 2015

The prevalence and correlates of the positive Androgen Deficiency in the Aging Male (ADAM) questionnaire among psychiatric outpatients: a cross-sectional survey of 176 men in a general hospital in Taiwan
Lee CP, Chen Y, Jiang KH, Chu CL, Hsu SC, Chen JL, Chen CY
Neuropsychiatric Disease and Treatment 2015, 11:185-189
Published Date: 20 January 2015

Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapine
Montgomery W, Kadziola Z, Ye W, Xue HB, Liu L, Treuer T
Neuropsychiatric Disease and Treatment 2015, 11:177-183
Published Date: 19 January 2015

Anxiety disorders and GABA neurotransmission: a disturbance of modulation
Nuss P
Neuropsychiatric Disease and Treatment 2015, 11:165-175
Published Date: 17 January 2015

Fish oil supplementation associated with decreased cellular degeneration and increased cellular proliferation 6 weeks after middle cerebral artery occlusion in the rat
Pascoe MC, Howells DW, Crewther DP, Carey LM, Crewther SG
Neuropsychiatric Disease and Treatment 2015, 11:153-164
Published Date: 14 January 2015

The role of family therapy in the management of schizophrenia: challenges and solutions
Caqueo-Urízar A, Rus-Calafell M, Urzúa A, Escudero J, Gutiérrez-Maldonado J
Neuropsychiatric Disease and Treatment 2015, 11:145-151
Published Date: 14 January 2015

Acute effects of single and multiple level thoracic manipulations on chronic mechanical neck pain: a randomized controlled trial
Puntumetakul R, Suvarnnato T, Werasirirat P, Uthaikhup S, Yamauchi J, Boucaut R
Neuropsychiatric Disease and Treatment 2015, 11:137-144
Published Date: 12 January 2015

Levomilnacipran for the treatment of major depressive disorder: a review
Asnis GA, Henderson MA
Neuropsychiatric Disease and Treatment 2015, 11:125-135
Published Date: 9 January 2015

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
Harada E, Schacht A, Koyama T, Marangell LB, Tsuji T, Escobar R
Neuropsychiatric Disease and Treatment 2015, 11:115-123
Published Date: 12 January 2015

Association between subjective actual sleep duration, subjective sleep need, age, body mass index, and gender in a large sample of young adults
Kalak N, Brand S, Beck J, Holsboer-Trachsler E, Wollmer MA
Neuropsychiatric Disease and Treatment 2015, 11:107-113
Published Date: 9 January 2015

Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities
Lozano D, Gonzales-Portillo GS, Acosta S, de la Pena I, Tajiri N, Kaneko Y, Borlongan CV
Neuropsychiatric Disease and Treatment 2015, 11:97-106
Published Date: 8 January 2015

An open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosis
Si TM, Tan QR, Zhang KR, Wang Y, Rui Q
Neuropsychiatric Disease and Treatment 2015, 11:87-95
Published Date: 6 January 2015

The impact of internalizing symptoms on autistic traits in adolescents with restrictive anorexia nervosa
Calderoni S, Fantozzi P, Balboni G, Pagni V, Franzoni E, Apicella F, Narzisi A, Maestro S, Muratori F
Neuropsychiatric Disease and Treatment 2015, 11:75-85
Published Date: 5 January 2015

Factors associated with the risk of relapse in schizophrenic patients after a response to electroconvulsive therapy: a retrospective study
Shibasaki C, Takebayashi M, Fujita Y, Yamawaki S
Neuropsychiatric Disease and Treatment 2015, 11:67-73
Published Date: 5 January 2015

Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies
Wang P, Li J, Qiu S, Wen H, Du J
Neuropsychiatric Disease and Treatment 2015, 11:59-66
Published Date: 31 December 2014

Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia
Sicras-Mainar A, Maurino J, Ruiz-Beato E, Navarro-Artieda R
Neuropsychiatric Disease and Treatment 2015, 11:51-57
Published Date: 30 December 2014

A study of safety and tolerability of rotatory vestibular input for preschool children
Su WC, Lin CK, Chang SC
Neuropsychiatric Disease and Treatment 2015, 11:41-49
Published Date: 31 December 2014

Defensive function of persecutory delusion and discrepancy between explicit and implicit self-esteem in schizophrenia: study using the Brief Implicit Association Test
Nakamura M, Hayakawa T, Okamura A, Kohigashi M, Fukui K, Narumoto J
Neuropsychiatric Disease and Treatment 2015, 11:33-40
Published Date: 22 December 2014

Clinical preference for factors in treatment of geriatric depression
Riepe MW
Neuropsychiatric Disease and Treatment 2015, 11:25-31
Published Date: 22 December 2014

Cerebellar cryptococcosis characterized by a space-occupying lesion in an immunocompetent non-HIV patient

Liu BX, Dai XJ, Liu H, Gong HH, Wang YX, Zhang LL
Neuropsychiatric Disease and Treatment 2015, 11:21-24
Published Date: 19 December 2014

Asn563Ser polymorphism of CD31/PECAM-1 is associated with atherosclerotic cerebral infarction in a southern Han population
Song YM, Li QF, Long LL, Zhang N, Liu YH
Neuropsychiatric Disease and Treatment 2015, 11:15-20
Published Date: 18 December 2014

Exploring the risk-factor association between depression and incident stroke: a systematic review and meta-analysis
Barlinn K, Kepplinger J, Puetz V, Illigens BM, Bodechtel U, Siepmann T
Neuropsychiatric Disease and Treatment 2015, 11:1-14
Published Date: 18 December 2014